News
History of Changes for Study: NCT
clinicaltrials.gov
Investigator: Peter Paschka. Official Title: PD. Dr. med. Affiliation: University of Ulm. Collaborators: Pfizer Nationales Centrum für Tumorerkrankungen ...
Agios to Present Updated Clinical Proof-of-Concept Data
www.globenewswire.com
– Data Supporting Utility of TIBSOVO® in AML and MDS Also Accepted for Presentation – – Agios to Host Investor Webcast on June 12 at 7:30 a.m. ET – ...
Protein Marker May Hold Key To Curing Some Types Of Leukemia
www.wave3.com
Dr. Peter Paschka and his team have linked a mutation on a certain protein to a higher risk of relapse. AML patients who test positive for this ...
sortiert nach Relevanz / Datum